Second-line (2L) treatment patterns and clinical outcomes among real-world (RW) patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with FOLFIRINOX (FFX) or gemcitabine + ...
Conversion Chemotherapy for Locally Advanced Pancreatic Carcinoma: FOLFIRINOX or Gemcitabine? The following represents disclosure information provided by authors of this manuscript. All relationships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results